Myosana Therapeutics (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- April 22, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $1,000,000
Company Info
- Founders
- Steve Runnels
- Company Description
- Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.
- Market
- Gene therapies for neuromuscular diseases
- Location
- Seattle, WA, USA
- Coinvestors
- CureDuchenne Ventures, Muscular Dystrophy Association, Parent Project Muscular Dystrophy